|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 501 to 600 out of 788 for Ncam2

0.03s
Type Details Score
Publication  
First Author: Stagni F
Year: 2016
Journal: Neuroscience
Title: Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome.
Volume: 333
Pages: 277-301
Publication
First Author: Fortress AM
Year: 2015
Journal: J Neurosci
Title: Designer receptors enhance memory in a mouse model of Down syndrome.
Volume: 35
Issue: 4
Pages: 1343-53
Publication
First Author: Incerti M
Year: 2012
Journal: PLoS One
Title: Prenatal treatment prevents learning deficit in Down syndrome model.
Volume: 7
Issue: 11
Pages: e50724
Publication
First Author: Stasko MR
Year: 2006
Journal: Neuroreport
Title: Hypothermic responses to 8-OH-DPAT in the Ts65Dn mouse model of Down syndrome.
Volume: 17
Issue: 8
Pages: 837-41
Publication      
First Author: Guedj F
Year: 2023
Journal: Biol Psychiatry
Title: The Impact of Mmu17 Non-Hsa21 Orthologous Genes in the Ts65Dn Mouse Model of Down Syndrome: The Gold Standard Refuted.
Publication
First Author: Letourneau A
Year: 2014
Journal: Nature
Title: Domains of genome-wide gene expression dysregulation in Down's syndrome.
Volume: 508
Issue: 7496
Pages: 345-50
Publication
First Author: Driscoll LL
Year: 2004
Journal: Behav Neurosci
Title: Impaired sustained attention and error-induced stereotypy in the aged Ts65Dn mouse: a mouse model of Down syndrome and Alzheimer's disease.
Volume: 118
Issue: 6
Pages: 1196-205
Publication  
First Author: Lomoio S
Year: 2009
Journal: Brain Res
Title: Beta-amyloid overload does not directly correlate with SAPK/JNK activation and tau protein phosphorylation in the cerebellar cortex of Ts65Dn mice.
Volume: 1297
Pages: 198-206
Publication
First Author: Hyde LA
Year: 2001
Journal: Behav Neurosci
Title: Age-related deficits in context discrimination learning in Ts65Dn mice that model Down syndrome and Alzheimer's disease.
Volume: 115
Issue: 6
Pages: 1239-46
Publication
First Author: Martínez-Cué C
Year: 1999
Journal: Neuroreport
Title: A murine model for Down syndrome shows reduced responsiveness to pain.
Volume: 10
Issue: 5
Pages: 1119-22
Publication
First Author: Costa AC
Year: 2005
Journal: Neurosci Lett
Title: Deficits in hippocampal CA1 LTP induced by TBS but not HFS in the Ts65Dn mouse: a model of Down syndrome.
Volume: 382
Issue: 3
Pages: 317-22
Publication
First Author: Sahir N
Year: 2006
Journal: J Mol Neurosci
Title: Neonatal mice of the Down syndrome model, Ts65Dn, exhibit upregulated VIP measures and reduced responsiveness of cortical astrocytes to VIP stimulation.
Volume: 30
Issue: 3
Pages: 329-40
Publication
First Author: Goodlett CR
Year: 2020
Journal: Sci Rep
Title: Evaluation of the therapeutic potential of Epigallocatechin-3-gallate (EGCG) via oral gavage in young adult Down syndrome mice.
Volume: 10
Issue: 1
Pages: 10426
Publication
First Author: Vorbrodt AW
Year: 2008
Journal: Brain Cell Biol
Title: Increased expression of beta-catenin in brain microvessels of a segmentally trisomic (Ts65Dn) mouse model of Down syndrome.
Volume: 36
Issue: 5-6
Pages: 203-11
Publication
First Author: Liu DP
Year: 2003
Journal: Biotechniques
Title: Quantitative PCR genotyping assay for the Ts65Dn mouse model of Down syndrome.
Volume: 35
Issue: 6
Pages: 1170-4, 1176, 1178 passim
Publication
First Author: Richtsmeier JT
Year: 2000
Journal: Dev Dyn
Title: Parallels of craniofacial maldevelopment in Down syndrome and Ts65Dn mice.
Volume: 217
Issue: 2
Pages: 137-45
Publication  
First Author: Duval N
Year: 2018
Journal: Front Aging Neurosci
Title: Rapamycin Treatment Ameliorates Age-Related Accumulation of Toxic Metabolic Intermediates in Brains of the Ts65Dn Mouse Model of Down Syndrome and Aging.
Volume: 10
Pages: 263
Publication
First Author: Deidda G
Year: 2015
Journal: Nat Med
Title: Reversing excitatory GABAAR signaling restores synaptic plasticity and memory in a mouse model of Down syndrome.
Volume: 21
Issue: 4
Pages: 318-26
Publication
First Author: Lockrow J
Year: 2009
Journal: Exp Neurol
Title: Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model.
Volume: 216
Issue: 2
Pages: 278-89
Publication
First Author: Galdzicki Z
Year: 2001
Journal: Brain Res Brain Res Rev
Title: On the cause of mental retardation in Down syndrome: extrapolation from full and segmental trisomy 16 mouse models.
Volume: 35
Issue: 2
Pages: 115-45
Publication  
First Author: Gautier MK
Year: 2023
Journal: Neurobiol Dis
Title: Maternal choline supplementation protects against age-associated cholinergic and GABAergic basal forebrain neuron degeneration in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.
Volume: 188
Pages: 106332
Publication  
First Author: Giacomini A
Year: 2015
Journal: Neurobiol Dis
Title: Inhibition of APP gamma-secretase restores Sonic Hedgehog signaling and neurogenesis in the Ts65Dn mouse model of Down syndrome.
Volume: 82
Pages: 385-396
Publication  
First Author: Begenisic T
Year: 2015
Journal: Neurobiol Dis
Title: Early environmental therapy rescues brain development in a mouse model of Down syndrome.
Volume: 82
Pages: 409-419
Publication
First Author: Jamal R
Year: 2022
Journal: PLoS One
Title: Increased dosage and treatment time of Epigallocatechin-3-gallate (EGCG) negatively affects skeletal parameters in normal mice and Down syndrome mouse models.
Volume: 17
Issue: 2
Pages: e0264254
Publication
First Author: Ramakrishna N
Year: 2009
Journal: Neuroscience
Title: Upregulation of beta-catenin expression in down syndrome model Ts65Dn mouse brain.
Volume: 161
Issue: 2
Pages: 451-8
Publication  
First Author: Alldred MJ
Year: 2021
Journal: Front Aging Neurosci
Title: Oxidative Phosphorylation Is Dysregulated Within the Basocortical Circuit in a 6-month old Mouse Model of Down Syndrome and Alzheimer's Disease.
Volume: 13
Pages: 707950
Publication
First Author: Scott-McKean JJ
Year: 2010
Journal: Invest Ophthalmol Vis Sci
Title: The mouse model of Down syndrome Ts65Dn presents visual deficits as assessed by pattern visual evoked potentials.
Volume: 51
Issue: 6
Pages: 3300-8
Publication  
First Author: Begenisic T
Year: 2014
Journal: Neurobiol Dis
Title: Fluoxetine in adulthood normalizes GABA release and rescues hippocampal synaptic plasticity and spatial memory in a mouse model of Down syndrome.
Volume: 63
Pages: 12-9
Publication
First Author: Harashima C
Year: 2006
Journal: J Comp Neurol
Title: Abnormal expression of the G-protein-activated inwardly rectifying potassium channel 2 (GIRK2) in hippocampus, frontal cortex, and substantia nigra of Ts65Dn mouse: a model of Down syndrome.
Volume: 494
Issue: 5
Pages: 815-33
Publication  
First Author: Dekker AD
Year: 2017
Journal: Neurobiol Dis
Title: Aging rather than aneuploidy affects monoamine neurotransmitters in brain regions of Down syndrome mouse models.
Volume: 105
Pages: 235-244
Publication  
First Author: Day SM
Year: 2019
Journal: eNeuro
Title: Glucagon-Like Peptide-1 Cleavage Product Improves Cognitive Function in a Mouse Model of Down Syndrome.
Volume: 6
Issue: 2
Publication  
First Author: Davisson MT
Year: 1999
Journal: Adv Neurochem
Title: Mouse models of Down Syndrome
Volume: 9
Pages: 297-327
Publication
First Author: Das I
Year: 2013
Journal: Sci Transl Med
Title: Hedgehog agonist therapy corrects structural and cognitive deficits in a Down syndrome mouse model.
Volume: 5
Issue: 201
Pages: 201ra120
Publication  
First Author: Altafaj X
Year: 2013
Journal: Neurobiol Dis
Title: Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome.
Volume: 52
Pages: 117-27
Publication
First Author: Hampton TG
Year: 2004
Journal: Physiol Behav
Title: Gait dynamics in trisomic mice: quantitative neurological traits of Down syndrome.
Volume: 82
Issue: 2-3
Pages: 381-9
Publication
First Author: Moore CS
Year: 2006
Journal: Mamm Genome
Title: Postnatal lethality and cardiac anomalies in the Ts65Dn Down syndrome mouse model.
Volume: 17
Issue: 10
Pages: 1005-12
Publication  
First Author: Powers BE
Year: 2017
Journal: Neuroscience
Title: Maternal choline supplementation in a mouse model of Down syndrome: Effects on attention and nucleus basalis/substantia innominata neuron morphology in adult offspring.
Volume: 340
Pages: 501-514
Publication
First Author: Chen Y
Year: 2009
Journal: Neurobiol Aging
Title: In vivo MRI identifies cholinergic circuitry deficits in a Down syndrome model.
Volume: 30
Issue: 9
Pages: 1453-65
Publication
First Author: Siarey RJ
Year: 1999
Journal: Neuropharmacology
Title: Increased synaptic depression in the Ts65Dn mouse, a model for mental retardation in Down syndrome.
Volume: 38
Issue: 12
Pages: 1917-20
Publication
First Author: Tyler WA
Year: 2013
Journal: J Neurosci
Title: Multiplex genetic fate mapping reveals a novel route of neocortical neurogenesis, which is altered in the Ts65Dn mouse model of Down syndrome.
Volume: 33
Issue: 12
Pages: 5106-19
Publication
First Author: Lysenko LV
Year: 2014
Journal: PLoS One
Title: Monoacylglycerol lipase inhibitor JZL184 improves behavior and neural properties in Ts65Dn mice, a model of down syndrome.
Volume: 9
Issue: 12
Pages: e114521
Publication  
First Author: Di Franco N
Year: 2022
Journal: Mol Cell Neurosci
Title: Differential expression of the neuronal CB1 cannabinoid receptor in the hippocampus of male Ts65Dn Down syndrome mouse model.
Volume: 119
Pages: 103705
Publication
First Author: Williams AD
Year: 2008
Journal: Dev Dyn
Title: Characterization of the cardiac phenotype in neonatal Ts65Dn mice.
Volume: 237
Issue: 2
Pages: 426-35
Publication
First Author: Sansevero G
Year: 2016
Journal: Exp Neurol
Title: Experience-dependent reduction of soluble β-amyloid oligomers and rescue of cognitive abilities in middle-age Ts65Dn mice, a model of Down syndrome.
Volume: 283
Issue: Pt A
Pages: 49-56
Publication
First Author: Kahlem P
Year: 2004
Journal: Genome Res
Title: Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of down syndrome.
Volume: 14
Issue: 7
Pages: 1258-67
Publication
First Author: Starbuck JM
Year: 2021
Journal: Sci Rep
Title: Green tea extracts containing epigallocatechin-3-gallate modulate facial development in Down syndrome.
Volume: 11
Issue: 1
Pages: 4715
Publication
First Author: Lyle R
Year: 2004
Journal: Genome Res
Title: Gene expression from the aneuploid chromosome in a trisomy mouse model of down syndrome.
Volume: 14
Issue: 7
Pages: 1268-74
Publication
First Author: Wenger GR
Year: 2004
Journal: Behav Genet
Title: Operant conditioning in the Ts65Dn mouse: learning.
Volume: 34
Issue: 1
Pages: 105-19
Publication
First Author: Hunter CL
Year: 2004
Journal: Neurobiol Aging
Title: Behavioral and neurobiological markers of Alzheimer's disease in Ts65Dn mice: effects of estrogen.
Volume: 25
Issue: 7
Pages: 873-84
Publication
First Author: Alldred MJ
Year: 2019
Journal: FASEB J
Title: Long-term effects of maternal choline supplementation on CA1 pyramidal neuron gene expression in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.
Volume: 33
Issue: 9
Pages: 9871-9884
Publication
First Author: O'Leary DA
Year: 2004
Journal: Biochim Biophys Acta
Title: Tissue-specific overexpression of the HSA21 gene GABPalpha: implications for DS.
Volume: 1739
Issue: 1
Pages: 81-7
Publication
First Author: Stasko MR
Year: 2004
Journal: Behav Brain Res
Title: Experimental parameters affecting the Morris water maze performance of a mouse model of Down syndrome.
Volume: 154
Issue: 1
Pages: 1-17
Publication
First Author: Kleschevnikov AM
Year: 2004
Journal: J Neurosci
Title: Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome.
Volume: 24
Issue: 37
Pages: 8153-60
Publication  
First Author: Trazzi S
Year: 2014
Journal: Neurobiol Dis
Title: APP-dependent alteration of GSK3β activity impairs neurogenesis in the Ts65Dn mouse model of Down syndrome.
Volume: 67
Pages: 24-36
Publication
First Author: Cowley PM
Year: 2012
Journal: Am J Physiol Regul Integr Comp Physiol
Title: Functional and biochemical characterization of soleus muscle in Down syndrome mice: insight into the muscle dysfunction seen in the human condition.
Volume: 303
Issue: 12
Pages: R1251-60
Publication
First Author: Blazek JD
Year: 2010
Journal: Dev Dyn
Title: Embryonic and not maternal trisomy causes developmental attenuation in the Ts65Dn mouse model for Down syndrome.
Volume: 239
Issue: 6
Pages: 1645-53
Publication
First Author: Hunter CL
Year: 2003
Journal: Neurosci Res
Title: Regional alterations in amyloid precursor protein and nerve growth factor across age in a mouse model of Down's syndrome.
Volume: 45
Issue: 4
Pages: 437-45
Publication
First Author: Saran NG
Year: 2003
Journal: Hum Mol Genet
Title: Global disruption of the cerebellar transcriptome in a Down syndrome mouse model.
Volume: 12
Issue: 16
Pages: 2013-9
Publication
First Author: Bimonte-Nelson HA
Year: 2003
Journal: Behav Brain Res
Title: Frontal cortex BDNF levels correlate with working memory in an animal model of Down syndrome.
Volume: 139
Issue: 1-2
Pages: 47-57
Publication
First Author: Victorino DB
Year: 2021
Journal: Sci Rep
Title: Atypical electrophysiological and behavioral responses to diazepam in a leading mouse model of Down syndrome.
Volume: 11
Issue: 1
Pages: 9521
Publication  
First Author: Catuara-Solarz S
Year: 2015
Journal: Front Behav Neurosci
Title: Principal Component Analysis of the Effects of Environmental Enrichment and (-)-epigallocatechin-3-gallate on Age-Associated Learning Deficits in a Mouse Model of Down Syndrome.
Volume: 9
Pages: 330
Publication
First Author: Llambrich S
Year: 2020
Journal: Sci Rep
Title: ViceCT and whiceCT for simultaneous high-resolution visualization of craniofacial, brain and ventricular anatomy from micro-computed tomography.
Volume: 10
Issue: 1
Pages: 18772
Publication
First Author: Shetty HU
Year: 2000
Journal: Neurochem Res
Title: Ts65Dn mouse, a Down syndrome model, exhibits elevated myo-inositol in selected brain regions and peripheral tissues.
Volume: 25
Issue: 4
Pages: 431-5
Publication
First Author: Kurt MA
Year: 2004
Journal: Brain Res
Title: Deficits of neuronal density in CA1 and synaptic density in the dentate gyrus, CA3 and CA1, in a mouse model of Down syndrome.
Volume: 1022
Issue: 1-2
Pages: 101-9
Publication
First Author: Chrast R
Year: 2000
Journal: Genome Res
Title: The mouse brain transcriptome by SAGE: differences in gene expression between P30 brains of the partial trisomy 16 mouse model of Down syndrome (Ts65Dn) and normals.
Volume: 10
Issue: 12
Pages: 2006-21
Publication
First Author: Möhler H
Year: 2012
Journal: Biochem Pharmacol
Title: Cognitive enhancement by pharmacological and behavioral interventions: the murine Down syndrome model.
Volume: 84
Issue: 8
Pages: 994-9
Publication
First Author: Megías M
Year: 1997
Journal: Neuroreport
Title: Cholinergic, serotonergic and catecholaminergic neurons are not affected in Ts65Dn mice.
Volume: 8
Issue: 16
Pages: 3475-8
Publication  
First Author: Begenisic T
Year: 2011
Journal: Front Cell Neurosci
Title: Environmental enrichment decreases GABAergic inhibition and improves cognitive abilities, synaptic plasticity, and visual functions in a mouse model of Down syndrome.
Volume: 5
Pages: 29
Publication
First Author: Hunter CL
Year: 2003
Journal: Behav Brain Res
Title: Behavioral comparison of 4 and 6 month-old Ts65Dn mice: age-related impairments in working and reference memory.
Volume: 138
Issue: 2
Pages: 121-31
Publication
First Author: Glass TJ
Year: 2016
Journal: PLoS One
Title: Digastric Muscle Phenotypes of the Ts65Dn Mouse Model of Down Syndrome.
Volume: 11
Issue: 6
Pages: e0158008
Publication
First Author: Moore CS
Year: 2010
Journal: Mamm Genome
Title: Increased male reproductive success in Ts65Dn "Down syndrome" mice.
Volume: 21
Issue: 11-12
Pages: 543-9
Publication
First Author: Best TK
Year: 2012
Journal: Exp Neurol
Title: Dysfunctional hippocampal inhibition in the Ts65Dn mouse model of Down syndrome.
Volume: 233
Issue: 2
Pages: 749-57
Publication
First Author: Munn RGK
Year: 2022
Journal: J Neurosci
Title: Hyper-Rigid Phasic Organization of Hippocampal Activity But Normal Spatial Properties of CA1 Place Cells in the Ts65Dn Mouse Model of Down Syndrome.
Volume: 42
Issue: 8
Pages: 1542-1556
Publication
First Author: Lorenzi HA
Year: 2006
Journal: Brain Res
Title: Hippocampal hypocellularity in the Ts65Dn mouse originates early in development.
Volume: 1104
Issue: 1
Pages: 153-9
Publication  
First Author: Emili M
Year: 2024
Journal: Neuropharmacology
Title: Reversal of neurodevelopmental impairment and cognitive enhancement by pharmacological intervention with the polyphenol polydatin in a Down syndrome model.
Volume: 261
Pages: 110170
Publication
First Author: Dierssen M
Year: 1997
Journal: Brain Res
Title: Alterations of central noradrenergic transmission in Ts65Dn mouse, a model for Down syndrome.
Volume: 749
Issue: 2
Pages: 238-44
Publication
First Author: Fernandez F
Year: 2008
Journal: Behav Brain Res
Title: Episodic-like memory in Ts65Dn, a mouse model of Down syndrome.
Volume: 188
Issue: 1
Pages: 233-7
Publication
First Author: Brandauer J
Year: 2024
Journal: Am J Physiol Regul Integr Comp Physiol
Title: Senescent hearts from male Ts65Dn mice exhibit preserved function but altered size and nicotinamide adenine dinucleotide pathway signaling.
Volume: 326
Issue: 2
Pages: R176-R183
Publication  
First Author: Jain S
Year: 2020
Journal: Neurosci Lett
Title: Neurodevelopmental wiring deficits in the Ts65Dn mouse model of Down syndrome.
Volume: 714
Pages: 134569
Publication
First Author: Choi JH
Year: 2009
Journal: J Neurochem
Title: Age-dependent dysregulation of brain amyloid precursor protein in the Ts65Dn Down syndrome mouse model.
Volume: 110
Issue: 6
Pages: 1818-27
Publication  
First Author: Palminiello S
Year: 2008
Journal: Brain Res
Title: Increased levels of carbonic anhydrase II in the developing Down syndrome brain.
Volume: 1190
Pages: 193-205
Publication
First Author: Herrera F
Year: 2009
Journal: Cell Death Differ
Title: Synaptojanin-1 plays a key role in astrogliogenesis: possible relevance for Down's syndrome.
Volume: 16
Issue: 6
Pages: 910-20
Publication
First Author: Contestabile A
Year: 2006
Journal: J Neurochem
Title: Choline acetyltransferase activity at different ages in brain of Ts65Dn mice, an animal model for Down's syndrome and related neurodegenerative diseases.
Volume: 97
Issue: 2
Pages: 515-26
Publication
First Author: Granholm AC
Year: 2000
Journal: Exp Neurol
Title: Loss of cholinergic phenotype in basal forebrain coincides with cognitive decline in a mouse model of Down's syndrome.
Volume: 161
Issue: 2
Pages: 647-63
Publication
First Author: Baxter LL
Year: 2000
Journal: Hum Mol Genet
Title: Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse.
Volume: 9
Issue: 2
Pages: 195-202
Publication  
First Author: Brose RD
Year: 2019
Journal: Front Aging Neurosci
Title: Hydroxyurea Improves Spatial Memory and Cognitive Plasticity in Mice and Has a Mild Effect on These Parameters in a Down Syndrome Mouse Model.
Volume: 11
Pages: 96
Publication
First Author: Moran TH
Year: 2002
Journal: Physiol Behav
Title: The effects of piracetam on cognitive performance in a mouse model of Down's syndrome.
Volume: 77
Issue: 2-3
Pages: 403-9
Publication  
First Author: Stagni F
Year: 2017
Journal: Neurobiol Dis
Title: Long-term effect of neonatal inhibition of APP gamma-secretase on hippocampal development in the Ts65Dn mouse model of Down syndrome.
Volume: 103
Pages: 11-23
Publication  
First Author: Nosheny RL
Year: 2015
Journal: Neurobiol Dis
Title: Increased cortical synaptic activation of TrkB and downstream signaling markers in a mouse model of Down Syndrome.
Volume: 77
Pages: 173-90
Publication
First Author: Galdzicki Z
Year: 2003
Journal: Genes Brain Behav
Title: Understanding mental retardation in Down's syndrome using trisomy 16 mouse models.
Volume: 2
Issue: 3
Pages: 167-78
Publication
First Author: Martínez-Cué C
Year: 2002
Journal: Behav Brain Res
Title: Differential effects of environmental enrichment on behavior and learning of male and female Ts65Dn mice, a model for Down syndrome.
Volume: 134
Issue: 1-2
Pages: 185-200
Publication
First Author: Granholm AC
Year: 2002
Journal: Physiol Behav
Title: Estrogen restores cognition and cholinergic phenotype in an animal model of Down syndrome.
Volume: 77
Issue: 2-3
Pages: 371-85
Publication
First Author: Dang V
Year: 2014
Journal: Biol Psychiatry
Title: Formoterol, a long-acting β2 adrenergic agonist, improves cognitive function and promotes dendritic complexity in a mouse model of Down syndrome.
Volume: 75
Issue: 3
Pages: 179-88
Publication
First Author: Olmos-Serrano JL
Year: 2016
Journal: Neuron
Title: Down Syndrome Developmental Brain Transcriptome Reveals Defective Oligodendrocyte Differentiation and Myelination.
Volume: 89
Issue: 6
Pages: 1208-1222
Publication  
First Author: Alemany-González M
Year: 2022
Journal: Neurobiol Dis
Title: Postnatal environmental enrichment enhances memory through distinct neural mechanisms in healthy and trisomic female mice.
Volume: 173
Pages: 105841
Publication
First Author: Kleschevnikov AM
Year: 2012
Journal: Neurobiol Dis
Title: Increased efficiency of the GABAA and GABAB receptor-mediated neurotransmission in the Ts65Dn mouse model of Down syndrome.
Volume: 45
Issue: 2
Pages: 683-91
Publication
First Author: Siarey RJ
Year: 2006
Journal: J Neurochem
Title: Altered signaling pathways underlying abnormal hippocampal synaptic plasticity in the Ts65Dn mouse model of Down syndrome.
Volume: 98
Issue: 4
Pages: 1266-77
Publication
First Author: Hyde LA
Year: 2001
Journal: Behav Brain Res
Title: Ts65Dn mice, a model for Down syndrome, have deficits in context discrimination learning suggesting impaired hippocampal function.
Volume: 118
Issue: 1
Pages: 53-60
Publication
First Author: Cooper JD
Year: 2001
Journal: Proc Natl Acad Sci U S A
Title: Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion.
Volume: 98
Issue: 18
Pages: 10439-44
Publication
First Author: Fuchs C
Year: 2012
Journal: Lab Invest
Title: Early-occurring proliferation defects in peripheral tissues of the Ts65Dn mouse model of Down syndrome are associated with patched1 over expression.
Volume: 92
Issue: 11
Pages: 1648-60